Objective: Reviews on child outcomes following in utero antidepressant exposure have
focused on short-term outcomes. However, several recent individual studies reported on …

OBJECTIVE: In weighing the risk and benefits of pharmacological treatment of depression
during pregnancy it is important to consider risks of long-term as well as short-term …

Importance Prenatal antidepressant exposure has been associated with adverse outcomes.
Previous studies, however, may not have adequately accounted for confounding. Objective …

Objective The aim of this study is to systematically review published studies, reporting
outcomes to offspring following in utero exposure to antidepressant medications, which used …

To investigate the association between intrauterine antidepressant exposure and offspring
affective disorders over an 18-year follow-up period using Danish national registers. We …

Children of women treated with antidepressants during pregnancy are more likely to
develop neurodevelopmental problems than are unexposed children. Associations between …

OBJECTIVE: This study evaluated the effects of prenatal antidepressant exposure on
perinatal outcomes, congenital malformations, and early growth and development …

Antidepressant and anxiolytic medications are widely prescribed and used by pregnant
women for acute and maintenance therapy. These drugs are able to pass the placental …

Objective: To perform an updated and comprehensive meta-analysis on the risks of adverse
perinatal outcomes in children whose mothers received antidepressants during pregnancy …

Background: Antidepressant use during pregnancy and the peripartum period is common
despite the absence of clear evidence-based guidelines to direct clinical use of these …